Carl Schmid, executive director of the HIV+Hepatitis Policy Institute in Washington, D.C., talks about the problems associated with generic HIV PrEP drug markups and potential ways to fix it.
President Donald Trump rolled back a Biden administration executive order aimed at lowering prescription drug prices, including an effort to make more generic drugs available to Medicare patients for ...
Retail drugs that have no generic equivalent and have been on the ... the HIV medication Biktarvy and the cancer drug Xtandi. The list price on Merck's diabetes drug Janumet increased 293% since ...
The prescription drug costs bill requires insurance companies to eliminate cost-sharing requirements for one generic drug and to cap co-payments on one brand-name drug at $25 per 30-day supply for ...
Jan 8 (Reuters) - Eli Lilly's (LLY.N), opens new tab obesity drug Zepbound can now be covered by government-backed Medicare insurance plans for use in sleep apnea, broadening access to the ...
and my main concern with this form of promotion is that it leads to a rapid and widespread escalation of the use of new drugs that are not necessarily better than similar generic drugs already in ...
saying the list of drugmakers conspired to overcharge the insurer, consumers and the federal government for generic drugs. The complaint (PDF), filed Dec. 31, claims the drugmakers communicated ...
The list price of Merck & Co.'s heavily discounted diabetes medications Januvia and Janumet will be lowered "to align the list price more closely to the net price. More drug price increases are likely ...